BioMarin Pharmaceutical (NASDAQ:BMRN)

Top Analyst Upgrades and Downgrades: Acacia, Baidu, BioMarin, Boeing, BP, CSX, Deere, HCA, PepsiCo, Redfin, S&P, Trimble, Visa, Zillow and More

Stocks were indicated to open slightly lower on Wednesday after Tuesday's equity trading recovered handily off the lows. All eyes will be on Federal Reserve Chair Jerome Powell's words on ...
Read Full Story »

Credit Suisse Best Ideas List Still Has 50% Implied Upside for 8 Stocks

With the three major stock indexes trading at or near all-time highs, many investors are scratching their heads about where to look for new investment ideas at a time when ...
Read Full Story »

Citigroup Sees Big Upside for 2 of the Largest Biotechs

After quite some time of muted or negative performance, big biotech may be worth a look again. Citigroup analyst Mohit Bansal assumed coverage of the large-cap biotech space and sees ...
Read Full Story »

5 Goldman Sachs Conviction List Stocks Have Gigantic Implied Upside

With 2019 well underway, and the first quarter almost over, many investors are resetting for what could be a more volatile rest of the year as the ongoing trade issues ...
Read Full Story »

5 Stocks on Goldman Sachs Conviction List With Massive Upside Potential

With 2019 off and running and the first quarter now almost half over, many investors are resetting for what could be a more volatile remainder of the year as the ...
Read Full Story »

Why 6 Top Biotech Stocks Could Beat Wall Street Q4 Estimates

If most investors thought their portfolios took a beating during the final quarter of 2018, it was a good thing they were not all-in on the biotechnology segment. The VanEck ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix, Sirius XM and More

Stocks entered the new year on a sour note, with equity futures down about 1.5% after weaker Chinese economic data. While investors used to buy every sell-off, the volatility in ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Activision, BioMarin, Ciena, Delta Air, GlaxoSmithKline, Procter & Gamble, Regeneron, Tesla and More

The futures traded down triple digits Friday morning as investors digested a very volatile trading week. Continued positive talk on trade, with China acknowledging the resumption of soybean and oil ...
Read Full Story »

Top Biotech Earnings Reports to Watch This Week

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week. While ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Athenahealth, Illumina, Northrop Grumman, Square, Twitter, Yamana Gold and More

Stocks were indicated to open marginally higher on Tuesday morning after a larger sell-off on Monday. Investors have been having less success buying the stock market dips in 2018 than in ...
Read Full Story »

Biopharma Companies to Watch This Week

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Biopharma Companies to Watch This Week and for the Rest of June

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Starbucks, Splunk, PayPal, L Brands, Medtronic, Gap, Novartis and More

The broad markets were looking soft ahead of the open on Friday, although hopefully not too soft as the Dow Jones industrial average and S&P 500 are looking to close ...
Read Full Story »

The Top Biopharma Catalysts Coming in May

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

The health care sector has yet to see any significant earnings representation, but that will change this week. In fact, pharmaceutical and biotech investors are about to get a real earnings ...
Read Full Story »